Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Róbert Královics | Researchclopedia

Back to researchers

Róbert Královics

CeMM Research Center for Molecular Medicine ORCID

254

Works

19,330

Citations

61

h-index

135

i10-index

Research Topics

Myeloproliferative Neoplasms: Diagnosis and Treatment Acute Myeloid Leukemia Research Chronic Myeloid Leukemia Treatments

Affiliations

Austrian Academy of Sciences2006–2022

Inserm2006–2006

German Cancer Research Center2002–2002

Baylor College of Medicine2001–2002

University of Basel2004–2008

Top Works

A Gain-of-Function Mutation of <i>JAK2</i> in Myeloproliferative Disorders

Róbert Královics,Francesco Passamonti,et al.

20053,438 citations

Eosinophilic Disorders and Syndromes

Kruppel-like factors research

Somatic Mutations of Calreticulin in Myeloproliferative Neoplasms

Thorsten Klampfl,Heinz Gisslinger,et al.

20131,953 citations

A Mutation in VPS35, Encoding a Subunit of the Retromer Complex, Causes Late-Onset Parkinson Disease

Alexander Zimprich,Anna Benet‐Pagès,et al.

2011898 citations

Genetic basis and molecular pathophysiology of classical myeloproliferative neoplasms

William Vainchenker,Róbert Královics

2016646 citations

Clonal evolution and clinical correlates of somatic mutations in myeloproliferative neoplasms

Pontus Lundberg,Axel Karow,et al.

2014637 citations

JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes

Elisa Rumi,Daniela Pietra,et al.

2013576 citations

Paul Ehrlich (1854-1915) and His Contributions to the Foundation and Birth of Translational Medicine

Peter Valent,Bernd Groner,et al.

2016404 citations

A common JAK2 haplotype confers susceptibility to myeloproliferative neoplasms

Damla Olcaydu,Ashot S. Harutyunyan,et al.

2009355 citations

Ropeginterferon alfa-2b versus standard therapy for polycythaemia vera (PROUD-PV and CONTINUATION-PV): a randomised, non-inferiority, phase 3 trial and its extension study

Heinz Gisslinger,Christoph Klade,et al.

2020335 citations